---
title: "Fudan-Zhangjiang Bio-Pharma Adopts Performance-Linked Pay Rules for Top Executives"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287914437.md"
description: "Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. has implemented new performance-linked pay rules for its top executives, approved at the annual general meeting on May 28, 2026. The rules aim to align compensation with national laws and corporate governance standards, focusing on fairness, long-term development, and performance assessment. This structured approach is intended to enhance management efficiency and support sustainable growth."
datetime: "2026-05-28T11:57:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287914437.md)
  - [en](https://longbridge.com/en/news/287914437.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287914437.md)
generator: "portal-rs"
---

# Fudan-Zhangjiang Bio-Pharma Adopts Performance-Linked Pay Rules for Top Executives

### Memorial Day Sale – Claim 70% Off TipRanks

-   Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.
-   Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter

An announcement from Shanghai Fudan Zhangjiang Bio Pharmaceutical Co ( (HK:1349) ) is now available.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. has adopted new Rules of Remuneration Management for directors and senior management, approved at its annual general meeting on 28 May 2026, to align pay practices with national laws and corporate governance standards. The rules apply to all directors and senior executives, covering the general manager, deputies, chief financial officer and board secretary, and are designed to build a scientific and effective incentive and restraint mechanism.

The framework sets out core principles, including fairness relative to company scale and industry benchmarks, alignment of pay with responsibilities and value creation, focus on long-term sustainable development and a balance between incentives and disciplinary measures. Remuneration will be closely tied to performance assessment, rewards and penalties, signaling a move to more structured, performance-linked compensation intended to enhance management efficiency and support the company’s stable, sustainable growth.

**More about Shanghai Fudan Zhangjiang Bio Pharmaceutical Co**

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. operates in the biopharmaceutical industry and focuses on developing and commercializing innovative drug products. The company is a listed entity in China and is governed by the Company Law, Securities Law and corporate governance guidelines that shape its operating and governance framework.

**Average Trading Volume:** 1,321,224

**Current Market Cap:** HK$837.8M

### Related Stocks

- [688505.CN](https://longbridge.com/en/quote/688505.CN.md)
- [01349.HK](https://longbridge.com/en/quote/01349.HK.md)
- [159992.CN](https://longbridge.com/en/quote/159992.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [159506.CN](https://longbridge.com/en/quote/159506.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [513700.CN](https://longbridge.com/en/quote/513700.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)

## Related News & Research

- [China to Foster New Pillar Industries in New Energy, Robotics, Biomedicine](https://longbridge.com/en/news/297036513.md)
- [Fudan Zhangjiang Invests RMB150 Million in Low-Risk Bank of China Structured Deposit](https://longbridge.com/en/news/291528523.md)
- [Fudan Zhangjiang Boosts Yield on Idle Cash With RMB210 Million SPD Bank Deposit](https://longbridge.com/en/news/291527210.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**